Invesco S&P SmallCap Health Care ETF (PSCH US)
PSCH US$55.05
20 minute delayed
14 days free access
Join Market Matters and get full access to all our Opinion + Action
Performance
Share price activity
- Last (Price)
- 55.05
- Change
- ▲ 0.30 (0.54)
- Bid / Ask
- 47.38 - 62.95
- Volume
- 1,091
- Turnover
- 48,914
- Open
- 55.01
- Day Range
- 54.97 - 55.05
- VWAP
- 55.02
- Prev Close
- 54.75
- Last Trade
- 28/10 4:00pm
Fund profile
Fund size
$173.8M
OCT 2026
Distributions
Quarterly
Since inception
16.6 yrs
APR 2010
- Legal name
- Invesco S&P SmallCap Health Care ETF
- Issuer
- Invesco
- Type
- Exchange-Traded Fund
- Structure
- Open Ended Investment Company
- Management style
- Index fund
- Morningstar category
- Health
- Category index
- Morningstar US Health TR USD
- Benchmark
- S&P Composite 1500 TR USD
- ETF net assets
- $173.8M
- Units on issue
- 3.2M
- Management fee
- 0.29% p.a.
- Domicile
- United States
- Base currency
- USD
- Inception
- 7 APR 2010
- Listed
- 7 APR 2010
Objective and strategy
The investment seeks to track the investment results (before fees and expenses) of the S&P SmallCap 600® Capped Health Care Index. The fund generally will invest at least 90% of its total assets in the securities that comprise the index. Strictly in accordance with its guidelines and mandated procedures, S&P Dow Jones Indices, LLC compiles, maintains and calculates the index, which is designed to measure the performance of securities of small-capitalization U.S. companies in the health care sector, as defined by the Global Industry Classification Standard.
Asset allocation
US equity 99.99%Non-US equity 0.01%
| Asset class | Net % | Long % | Short % |
|---|---|---|---|
| Equity | 99.99 | 99.99 | — |
| Bond | 0.00 | 0.00 | — |
| Cash | 0.01 | 0.01 | — |
| Other | 0.00 | 0.00 | — |
Sector exposure
Cyclical 1.35%Sensitive 0.00%Defensive 98.64%
- Basic Materials
- 0.00%
- Consumer Cyclical
- 0.00%
- Financial Services
- 1.35%
- Real Estate
- 0.00%
- Communication Services
- 0.00%
- Energy
- 0.00%
- Industrials
- 0.00%
- Technology
- 0.00%
- Consumer Defensive
- 0.00%
- Healthcare
- 98.64%
- Utilities
- 0.00%
Region exposure
Developed markets 99.99%Emerging markets 0.00%
- North America
- 99.99%
- Latin America
- 0.00%
- United Kingdom
- 0.00%
- Europe Developed
- 0.00%
- Europe Emerging
- 0.00%
- Africa / Middle East
- 0.00%
- Japan
- 0.00%
- Australasia
- 0.00%
- Asia Developed
- 0.00%
- Asia Emerging
- 0.00%
Country exposure
- United States
- 99.99%
Style box
- Style
- Small Growth
Size score
-3
Value-growth score
205
Economic moat
Wide 0%Narrow 37%None 63%
Market capitalisation
- Giant
- 0.00%
- Large
- 0.00%
- Mid
- 0.00%
- Small
- 47.09%
- Micro
- 52.90%
Small 47%Micro 53%
- Average market cap
- $3.54B
- Number of holdings
- 73
- Shares held
- 69
Portfolio statistics · 23 OCT 2026
- Price / earnings
- 25.23
- Price / book
- 2.80
- Price / sales
- 2.00
- Price / cash flow
- 14.32
- Dividend yield
- 0.21%
- Assets in top 10
- 34.90%
- Return on equity
- 8.06%
- Net margin
- 6.27%
Top holdings · top 10 = 34.91% of assets
| Holding | % Weight | First bought | Market value | Currency | Units held | Sector | Country | |
|---|---|---|---|---|---|---|---|---|
| Glaukos Corp GKOS | 5.22 | MAR 2020 | 9.3M | USD | 56,769 | Healthcare | United States | |
| Protagonist Therapeutics Inc PTGX | 4.91 | JUL 2024 | 8.8M | USD | 62,279 | Healthcare | United States | |
| TG Therapeutics Inc TGTX | 4.26 | SEP 2024 | 7.6M | USD | 136,506 | Healthcare | United States | |
| Alkermes PLC ALKS | 3.66 | DEC 2023 | 6.5M | USD | 161,430 | Healthcare | United States | |
| Ligand Pharmaceuticals Inc LGND | 3.36 | SEP 2021 | 6.0M | USD | 19,183 | Healthcare | United States | |
| PTC Therapeutics Inc PTCT | 2.91 | NOV 2025 | 5.2M | USD | 80,293 | Healthcare | United States | |
| Teleflex Inc TFX | 2.85 | MAR 2025 | 5.1M | USD | 40,762 | Healthcare | United States | |
| Merit Medical Systems Inc MMSI | 2.77 | APR 2010 | 5.0M | USD | 57,442 | Healthcare | United States | |
| RadNet Inc RDNT | 2.63 | NOV 2019 | 4.7M | USD | 68,136 | Healthcare | United States | |
| Integer Holdings Corp ITGR | 2.31 | APR 2010 | 4.1M | USD | 32,699 | Healthcare | United States |
Trailing returns · 30 SEP 2026
Fund (NAV) Market price
1M
-4.6
3M
-0.7
6M
26.3
YTD
18.0
1Y
25.0
3Y
11.6
5Y
-3.0
10Y
7.8
| Period | Fund (NAV) % | Market price % | Before fees % | Rank in category |
|---|---|---|---|---|
| 1 month | -4.64 | -4.65 | -4.61 | 83 / 176 |
| 3 months | -0.67 | -0.57 | -0.60 | 75 / 175 |
| 6 months | 26.31 | 26.55 | 26.49 | 18 / 171 |
| Year to date | 18.03 | 18.19 | 18.29 | 33 / 171 |
| 1 year | 25.04 | 25.16 | 25.40 | 49 / 170 |
| 3 years p.a. | 11.58 | 11.64 | 11.90 | 66 / 160 |
| 5 years p.a. | -3.00 | -3.00 | -2.72 | 90 / 153 |
| 10 years p.a. | 7.78 | 7.80 | 8.10 | 90 / 121 |
Returns to 30 SEP 2026, periods of 3 years and longer annualised. Rank is the percentile in the Morningstar category at 30 SEP 2026 (1 = best) over the funds ranked.
Calendar year returns
Total Capital
2016
1.9
2017
34.4
2018
9.7
2019
19.9
2020
31.1
2021
5.6
2022
-26.3
2023
-2.6
2024
3.7
2025
-0.5
| Year | Total % | Capital % | Rank in category |
|---|---|---|---|
| 2025 | -0.50 | -0.54 | 97 / 172 |
| 2024 | 3.75 | 3.47 | 29 / 176 |
| 2023 | -2.62 | -2.63 | 85 / 176 |
| 2022 | -26.32 | -26.32 | 81 / 176 |
| 2021 | 5.62 | 5.62 | 63 / 166 |
| 2020 | 31.14 | 31.14 | 26 / 157 |
| 2019 | 19.91 | 19.91 | 78 / 145 |
| 2018 | 9.69 | 9.69 | 7 / 140 |
| 2017 | 34.43 | 34.43 | 15 / 144 |
| 2016 | 1.95 | 1.92 | 4 / 134 |
| 2015 | 20.29 | 20.29 | 1 / 128 |
Risk statistics · 30 SEP 2026
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Alpha | 14.51 | -5.43 | -12.13 | -3.17 |
| Beta | 0.49 | 0.88 | 0.89 | 1.01 |
| R-squared | 10.57 | 24.45 | 39.98 | 48.82 |
| Standard deviation | 21.40 | 21.33 | 21.01 | 21.24 |
| Sharpe ratio | 0.97 | 0.40 | -0.23 | 0.34 |
| Sortino ratio | 2.39 | 0.74 | -0.33 | 0.52 |
| Tracking error | 21.50 | 18.60 | 16.31 | 15.24 |
| Information ratio | 0.39 | -0.55 | -0.89 | -0.30 |
| Upside capture % | 38.55 | 66.26 | 58.80 | 89.18 |
| Downside capture % | -138.63 | 92.37 | 117.55 | 108.95 |
| Maximum drawdown % | -9.94 | -20.06 | -41.27 | -44.60 |
Measured against MSCI ACWI NR USD with USTREAS T-Bill Auction Ave 3 Mon as the risk-free rate, to 30 SEP 2026. Maximum drawdown is on gross returns at the latest quarter end.
Portfolio risk score
Risk score
91.8
Morningstar Portfolio Risk Score at 30 SEP 2026.
- Market impact cost %
- 0.020
- Best quarter
- 35.12% · JAN 2021
- Worst quarter
- -23.07% · DEC 2018
Fees and costs
- Management fees and costs
- 0.29% p.a.
- PDS dated
- 19 DEC 2025
Distributions
- Latest distribution
- 0.0003
- Ex Date
- 23 MAR 2026
- Record Date
- 23 MAR 2026
- Pay Date
- 27 MAR 2026
- NAV at ex date
- 40.09
- Paid this year
- 0.0003
Distributions by year
2024
0.0
2023
0.1
2022
0.0
2017
0.0
2015
0.0
| Year | Per unit ($) |
|---|---|
| 2024 | 0.0188 |
| 2023 | 0.1201 |
| 2022 | 0.0045 |
| 2017 | 0.0017 |
| 2015 | 0.0065 |
Distribution history
| Ex Date | Per unit ($) |
|---|---|
| 23 MAR 2026 | 0.0003 |
| 22 SEP 2025 | 0.0026 |
| 23 JUN 2025 | 0.0020 |
| 24 MAR 2025 | 0.0142 |
| 23 DEC 2024 | 0.0180 |
| 24 JUN 2024 | 0.0659 |
| 18 MAR 2024 | 0.0361 |
| 18 DEC 2023 | 0.0045 |
| 24 SEP 2018 | 0.0017 |
| 16 DEC 2016 | 0.0065 |
| 24 DEC 2014 | 0.4802 |
| 19 DEC 2014 | 0.0092 |
Sustainability rating · 31 AUG 2026
Below Average
ESG risk score
27.52
Category average 21.96
- Rank in category
- 86th percentile of 594 funds
- Environmental risk
- 0.67
- Social risk
- 2.80
- Governance risk
- 1.04
- Portfolio covered
- 94.2%
ESG risk of holdings
- Negligible
- 0.00%
- Low
- 7.91%
- Medium
- 52.97%
- High
- 39.12%
- Severe
- 0.00%
0.00% of assets are in companies with high or severe controversies.
Carbon · 31 AUG 2026
Carbon risk score
4.69
Category average 2.74
- Carbon risk
- Low Risk
- Rank in category
- 78th percentile of 313 funds
- Fossil fuel involvement
- 0.00%
- Category average
- 0.16%
- Low Carbon Designation
- Yes
- Portfolio covered
- 94.2%
Fund managers
- Peter Hubbard
- Michael Jeanette
- Pratik Doshi
Tenure
- Number of managers
- 3
- Average tenure
- 13.3 years
- Longest tenure
- 16.5 years
- Longest serving
- Peter Hubbard, Michael Jeanette · since 7 APR 2010
- Most recent appointment
- Pratik Doshi · since 20 DEC 2019
- Managed since
- 7 APR 2010
- Other funds managed
- 292
Announcements
Announcements are available for ASX-listed companies only.
Opinion
No opinions for this company yet.
Action
No actions for this company yet.